CRISPR-话题@MedSci

#CRISPR#

417篇内容 | 4546人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276020, encodeId=1bb212e60208a, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Science Advances：重磅！研究人员使用CRISPR-Cpf1治疗杜氏肌营养不良, objectType=article, longId=96280, objectId=06229628060, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06229628060, replyNumber=0, likeNumber=57, createdTime=2017-04-19, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06229628060, moduleTitle=Science Advances：重磅！研究人员使用CRISPR-Cpf1治疗杜氏肌营养不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06229628060)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276019, encodeId=632612e6019e0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature: 无所不能的CRISPR，居然还可用于疾病检测, objectType=article, longId=96026, objectId=4e61960264d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e61960264d, replyNumber=0, likeNumber=47, createdTime=2017-04-18, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e61960264d, moduleTitle=Nature: 无所不能的CRISPR，居然还可用于疾病检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e61960264d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276018, encodeId=aa7812e601825, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Science：张锋团队今日带来 CRISPR 重磅新应用，核酸检测灵敏度可达单分子, objectType=article, longId=95959, objectId=01049595931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01049595931, replyNumber=0, likeNumber=100, createdTime=2017-04-16, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01049595931, moduleTitle=Science：张锋团队今日带来 CRISPR 重磅新应用，核酸检测灵敏度可达单分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01049595931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276017, encodeId=534612e60176d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Biotechnol：CRISPR单碱基编辑准确！, objectType=article, longId=95861, objectId=bf5a9586174, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf5a9586174, replyNumber=0, likeNumber=58, createdTime=2017-04-16, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf5a9586174, moduleTitle=Nat Biotechnol：CRISPR单碱基编辑准确！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf5a9586174)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276016, encodeId=d6e212e60160d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=【盘点】资本热捧，CRISPR加持，协同致死效应成为抗癌新药研发的一匹黑马, objectType=article, longId=95578, objectId=d345955e812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d345955e812, replyNumber=0, likeNumber=62, createdTime=2017-04-14, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d345955e812, moduleTitle=【盘点】资本热捧，CRISPR加持，协同致死效应成为抗癌新药研发的一匹黑马, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d345955e812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276015, encodeId=299712e6015e6, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature：如果CRISPR的结果与其它结果不一致？, objectType=article, longId=95221, objectId=901d9522140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=901d9522140, replyNumber=0, likeNumber=64, createdTime=2017-04-10, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=901d9522140, moduleTitle=Nature：如果CRISPR的结果与其它结果不一致？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=901d9522140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276014, encodeId=264912e6014fc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Biotechn：CRISPR筛选发现非编码DNA的调控功能, objectType=article, longId=95018, objectId=c95995018e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95995018e4, replyNumber=0, likeNumber=47, createdTime=2017-04-09, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95995018e4, moduleTitle=Nat Biotechn：CRISPR筛选发现非编码DNA的调控功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95995018e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276013, encodeId=337412e6013da, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=一篇文章让他从神坛跌为众矢之的，《CRISPR的英雄们》背后的始末, objectType=article, longId=94864, objectId=678a9486465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=678a9486465, replyNumber=0, likeNumber=57, createdTime=2017-04-08, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=678a9486465, moduleTitle=一篇文章让他从神坛跌为众矢之的，《CRISPR的英雄们》背后的始末, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=678a9486465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276012, encodeId=7ec012e6012be, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=NAT COMMUN：利用CRISPR治疗视网膜色素变性, objectType=article, longId=94685, objectId=65ea946856c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65ea946856c, replyNumber=0, likeNumber=67, createdTime=2017-04-06, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65ea946856c, moduleTitle=NAT COMMUN：利用CRISPR治疗视网膜色素变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65ea946856c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276011, encodeId=bd7312e601185, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Cell：揭示抗CRISPR蛋白阻断CRISPR系统机制, objectType=article, longId=94560, objectId=d6d4945601e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d4945601e, replyNumber=0, likeNumber=77, createdTime=2017-04-05, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d4945601e, moduleTitle=Cell：揭示抗CRISPR蛋白阻断CRISPR系统机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6d4945601e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276010, encodeId=d94812e60105c, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature：他是张锋关键Science论文的共同作者，全新CRISPR成果再登Nature！, objectType=article, longId=94528, objectId=873494528e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873494528e1, replyNumber=0, likeNumber=57, createdTime=2017-04-05, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873494528e1, moduleTitle=Nature：他是张锋关键Science论文的共同作者，全新CRISPR成果再登Nature！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=873494528e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276009, encodeId=401d12e6009b5, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=eLife：挑战常规！利用CRISPR-Cas9突变证实癌基因MELK其实并不致癌, objectType=article, longId=93970, objectId=3897939e0d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3897939e0d1, replyNumber=0, likeNumber=122, createdTime=2017-03-31, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3897939e0d1, moduleTitle=eLife：挑战常规！利用CRISPR-Cas9突变证实癌基因MELK其实并不致癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3897939e0d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276008, encodeId=396212e60082f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=一波新的CRISPR工具浮出水面, objectType=article, longId=93969, objectId=9eb09396903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eb09396903, replyNumber=0, likeNumber=60, createdTime=2017-03-30, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eb09396903, moduleTitle=一波新的CRISPR工具浮出水面, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eb09396903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276007, encodeId=9f0b12e600774, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=CRISPR专利故事跌宕起伏，这一次张锋输了……, objectType=article, longId=93685, objectId=f5d69368591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d69368591, replyNumber=0, likeNumber=68, createdTime=2017-03-29, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d69368591, moduleTitle=CRISPR专利故事跌宕起伏，这一次张锋输了……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5d69368591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276006, encodeId=9ed812e600670, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=以“基因剪刀”CRISPR&#160/&#160Cas9技术为基础，创新基因疗法问世, objectType=article, longId=92947, objectId=64499294e80, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64499294e80, replyNumber=0, likeNumber=68, createdTime=2017-03-24, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64499294e80, moduleTitle=以“基因剪刀”CRISPR&#160/&#160Cas9技术为基础，创新基因疗法问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64499294e80)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276005, encodeId=c0b612e600536, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Methods：利用CRISPR–Cas9组合筛选发现癌症弱点, objectType=article, longId=92954, objectId=ae309295443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae309295443, replyNumber=0, likeNumber=76, createdTime=2017-03-23, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae309295443, moduleTitle=Nat Methods：利用CRISPR–Cas9组合筛选发现癌症弱点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae309295443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276004, encodeId=bab212e60045a, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=【盘点】CRISPR基因编辑技术或有望治疗癌症和HIV等顽疾, objectType=article, longId=92539, objectId=b97692539c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97692539c3, replyNumber=0, likeNumber=74, createdTime=2017-03-21, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97692539c3, moduleTitle=【盘点】CRISPR基因编辑技术或有望治疗癌症和HIV等顽疾, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97692539c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276003, encodeId=720d12e6003f3, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Commun：治疗失明新策略！利用CRISPR阻止视网膜退化！, objectType=article, longId=92123, objectId=a5aa9212333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5aa9212333, replyNumber=0, likeNumber=73, createdTime=2017-03-17, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5aa9212333, moduleTitle=Nat Commun：治疗失明新策略！利用CRISPR阻止视网膜退化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5aa9212333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276002, encodeId=349712e600209, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature：用CRISPR/Cas9技术将肿瘤抗原受体编辑进T细胞TRAC基因位点，增强杀死癌细胞的能力, objectType=article, longId=91304, objectId=06389130465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06389130465, replyNumber=0, likeNumber=116, createdTime=2017-03-11, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06389130465, moduleTitle=Nature：用CRISPR/Cas9技术将肿瘤抗原受体编辑进T细胞TRAC基因位点，增强杀死癌细胞的能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06389130465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276001, encodeId=219212e6001bf, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=专家指路：如何追上CRISPR技术快速发展的脚步？, objectType=article, longId=91242, objectId=2b5f9124229, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b5f9124229, replyNumber=0, likeNumber=72, createdTime=2017-03-11, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b5f9124229, moduleTitle=专家指路：如何追上CRISPR技术快速发展的脚步？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b5f9124229)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CRISPR

2020-05-29

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Science Advances：重磅！研究人员使用CRISPR-Cpf1治疗杜氏肌营养不良

2017-04-19

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature: 无所不能的CRISPR，居然还可用于疾病检测

2017-04-18

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Science：张锋团队今日带来 CRISPR 重磅新应用，核酸检测灵敏度可达单分子

2017-04-16

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Biotechnol：CRISPR单碱基编辑准确！

2017-04-16

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

【盘点】资本热捧，CRISPR加持，协同致死效应成为抗癌新药研发的一匹黑马

2017-04-14

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature：如果CRISPR的结果与其它结果不一致？

2017-04-10

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Biotechn：CRISPR筛选发现非编码DNA的调控功能

2017-04-09

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

一篇文章让他从神坛跌为众矢之的，《CRISPR的英雄们》背后的始末

2017-04-08

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

NAT COMMUN：利用CRISPR治疗视网膜色素变性

2017-04-06

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Cell：揭示抗CRISPR蛋白阻断CRISPR系统机制

2017-04-05

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature：他是张锋关键Science论文的共同作者，全新CRISPR成果再登Nature！

2017-04-05

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

eLife：挑战常规！利用CRISPR-Cas9突变证实癌基因MELK其实并不致癌

2017-03-31

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

一波新的CRISPR工具浮出水面

2017-03-30

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

CRISPR专利故事跌宕起伏，这一次张锋输了……

2017-03-29

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

以“基因剪刀”CRISPR&#160/&#160Cas9技术为基础，创新基因疗法问世

2017-03-24

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Methods：利用CRISPR–Cas9组合筛选发现癌症弱点

2017-03-23

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

【盘点】CRISPR基因编辑技术或有望治疗癌症和HIV等顽疾

2017-03-21

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Commun：治疗失明新策略！利用CRISPR阻止视网膜退化！

2017-03-17

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature：用CRISPR/Cas9技术将肿瘤抗原受体编辑进T细胞TRAC基因位点，增强杀死癌细胞的能力

2017-03-11

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

专家指路：如何追上CRISPR技术快速发展的脚步？

2017-03-11

科室
- - 订阅+
  - 更多科室
工具
服务